Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
PVRIG inhibitor
DRUG CLASS:
PVRIG inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
COM701 (1)
NTX2R13 (0)
TGI-2 (0)
COM701 (1)
NTX2R13 (0)
TGI-2 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TMB-L
Breast Cancer
TMB-L
Breast Cancer
nivolumab + COM701
Sensitive: C3 – Early Trials
nivolumab + COM701
Sensitive
:
C3
nivolumab + COM701
Sensitive: C3 – Early Trials
nivolumab + COM701
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login